Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    New film ‘proves beyond shadow of a doubt’ that Elgin Marbles were stolen, director claims | Ents & Arts News

    Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032

    Washington's Zoom Diallo sets up Franck Kepnang for the throwdown vs. Denver

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»Medicare Expands GLP-1 Coverage as MENU ORDER AI Prepares App Store Debut for the High-Protein / GLP-1 Dining Revolution
    Health

    Medicare Expands GLP-1 Coverage as MENU ORDER AI Prepares App Store Debut for the High-Protein / GLP-1 Dining Revolution

    AdminBy AdminNo Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    As the only health-tech app designed specifically for GLP-1 users who dine out — and for restaurants eager to welcome them back — MENU ORDER AI combines AI-powered menu scanning with real-time nutrition intelligence to help millions “Eat anywhere. Order smarter.”

    BOSTON, Nov. 6, 2025 /PRNewswire/ — Following news that Medicare will expand coverage for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, MENU ORDER AI is preparing for its App Store debut—timed perfectly to serve the nation’s growing population of GLP-1 users and health-conscious diners.

    After months of beta testing and feedback, MENU ORDER AI has undergone imperative and revolutionary changes that make it a next-generation dining companion. Founder and CEO Melissa Butler said the new version delivers faster restaurant suggestions and smarter menu recommendations, helping users instantly discover meals that match their health goals. With these updates complete and App Store approval pending, the app is nearly ready to launch.

    “We’ve built MENU ORDER AI  for the real world—for GLP-1 users who still love to dine out and for restaurants that want to welcome them back,” said Melissa Butler, Founder & CEO. “Our app isn’t about restriction; it’s about confidence, freedom, and smarter choices powered by AI.”

    The app’s Smart Menu Engine analyzes real restaurant menus in seconds to reveal GLP-1-friendly, High-protein, Low-carbohydrate, and Low WW point meals. It then suggests subtle “Smart Tweaks”—like skipping the bun, swapping sides, or even keeping the fries—so users can stay on track without sacrificing enjoyment. Integrated with leading restaurants, reservation, and delivery platforms, MENU ORDER AI bridges health-focused diners and restaurants eager to reach them.

    MENU ORDER AI is wholly owned by ORDER AI LLC and was founded and created under Butler’s direction. Engineering was executed by Weblynx and Muhammad Bilal, who served as paid contractors under her supervision. This collaboration produced a secure, responsive system built for scalability, real-time data, and evolving AI frameworks.

    MENU ORDER AI will soon be available on the Apple App Store. Users can join the waitlist now at www.orderappai.com for early access and launch updates.

    Melissa Butler
    Founder / CEO
    Melissa Butler
    [email protected]

    This release was issued through WebWire®. For more information, visit http://www.webwire.com.

    SOURCE MENU – ORDER AI

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032

    La Fundación Michael J. Fox para la Investigación sobre Parkinson celebra a los votantes de Texas por la aprobación de la Proposición 14 que asegura $3 mil millones para la investigación de enfermedades cerebrales USA – español USA – English

    UPL startet im Vorfeld der COP30 die globale Kampagne „#AFarmerCan”, die sich für Landwirte im Klimaschutz einsetzt

    DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Judge reverses Trump administration’s cuts of billions of dollars to Harvard University

    Prabowo jets to meet Xi in China after deadly Indonesia protests

    This HP laptop with an astonishing 32GB of RAM is just $261

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2025 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.